Impact of the anti-inflammatory agent bindarit on the chemokinome: selective inhibition of the monocyte chemotactic proteins.

Massimiliano Mirolo(Fondazione Telethon), Alberto Mantovani(Humanitas University), Marco Fabbri(Humanitas University), Angelo Guglielmotti(Angelini Pharma (Italy)), Marina Sironi(Humanitas University), Giuseppe Biondi(Angelini Pharma (Italy)), Massimo Locati(University of Milan), Annunciata Vecchi(Mario Negri Institute for Pharmacological Research), Giorgina Mangano(Angelini Pharma (Italy))
PubMed
September 1, 2008
Cited by 63


Related Papers